YCBD

AMEX

cbdMD Inc.

SectorConsumer DiscretionaryIndustryPackage Goods/CosmeticsIPO2017

News25/Ratings0

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.

News · 26 weeks38+350%

2025-10-262026-04-19

Mix1790d

Insider6(35%)
SEC Filings5(29%)
Other4(24%)
Earnings2(12%)

Latest news

25 items

7dINSIDER
SEC Form 4 filed by Porter Jeffrey H
4 - cbdMD, Inc. (0001644903) (Issuer)
7dINSIDER
SEC Form 4 filed by Roe Kevin Charles
4 - cbdMD, Inc. (0001644903) (Issuer)
7dINSIDER
SEC Form 4 filed by Swift Sibyl Nichole
4 - cbdMD, Inc. (0001644903) (Issuer)
7dINSIDER
SEC Form 4 filed by Sellers Bakari T.
4 - cbdMD, Inc. (0001644903) (Issuer)
7dINSIDER
SEC Form 4 filed by Stephen Scott G.
4 - cbdMD, Inc. (0001644903) (Issuer)
7dINSIDER
SEC Form 4 filed by Raines William F Iii
4 - cbdMD, Inc. (0001644903) (Issuer)
8dSEC
cbdMD Inc. filed SEC Form 8-K: Other Events
8-K - cbdMD, Inc. (0001644903) (Filer)
22dSEC
cbdMD Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - cbdMD, Inc. (0001644903) (Filer)
22dPR
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
Company brings one of the only combined clinical and toxicological safety dataset in the hemp-derived CBD category into a new provider channel as CMS activates cannabinoid access within value-based care modelsCHARLOTTE, N.C., April 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leader in science-driven cannabinoid products, today announced the launch of its clinical healthcare channel, positioning the Company to support physicians, health systems, and value-based care organizations as federal policy establishes structured pathways for hemp-derived cannabinoid products within Medicare programs.
50dSEC
SEC Form EFFECT filed by cbdMD Inc.
EFFECT - cbdMD, Inc. (0001644903) (Filer)
50dSEC
SEC Form 424B4 filed by cbdMD Inc.
424B4 - cbdMD, Inc. (0001644903) (Filer)
65dPR
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a
65dSEC
SEC Form 10-Q filed by cbdMD Inc.
10-Q - cbdMD, Inc. (0001644903) (Filer)
70dPR
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results
CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.
80dPR
cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum
CHARLOTTE, N.C., Feb. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in wellness and hemp-derived consumer products, today announced a major distribution expansion for its Herbal Oasis THC-infused social seltzer ("Oasis") through an expanded partnership with Morales Beverage Group ("MBG"). The agreement extends Oasis into Louisiana, strengthening the brand's regional footprint across the Gulf South and creating a more contiguous platform for continued Southeast growth, following strong early performance in Texas. With MBG's established statewide distribut
83dSEC
SEC Form PRE 14A filed by cbdMD Inc.
PRE 14A - cbdMD, Inc. (0001644903) (Filer)
84dPR
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
CHARLOTTE, N.C., Jan. 29, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in hemp-derived wellness products, today announced a strategic initiative to integrate and expand its regulatory science, safety, and intellectual property assets to establish a differentiated cannabinoid compliance and evidence platform aligned with evolving federal healthcare evaluation frameworks, including emerging CMS and CMMI innovation initiatives. The program combines scientific and regulatory assets acquired through cbdMD's recent acquisition of Bluebird Botanicals ("Bluebird")
91dSEC
SEC Form S-1 filed by cbdMD Inc.
S-1 - cbdMD, Inc. (0001644903) (Filer)
93dSEC
Amendment: SEC Form 10-K/A filed by cbdMD Inc.
10-K/A - cbdMD, Inc. (0001644903) (Filer)
99dSEC
SEC Form 424B3 filed by cbdMD Inc.
424B3 - cbdMD, Inc. (0001644903) (Filer)
99dPR
cbdMD Announces Strategic Acquisition of Bluebird Botanicals
CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- cbdMD, Inc (NYSE:YCBD), a leading innovator in hemp-derived wellness products, announced today the closing of the acquisition of substantially all of the assets of Bluebird Botanicals, one of the longest-standing brands in the CBD industry, providing an established and complementary revenue base to strengthen cbdMD's long-term growth strategy. The transaction was completed through an asset purchase comprised of an initial share issuance and earnout shares. For more details, including specific terms and conditions, please see the
100dSEC
SEC Form EFFECT filed by cbdMD Inc.
EFFECT - cbdMD, Inc. (0001644903) (Filer)
100dSEC
cbdMD Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - cbdMD, Inc. (0001644903) (Filer)
116dSEC
SEC Form EFFECT filed by cbdMD Inc.
EFFECT - cbdMD, Inc. (0001644903) (Filer)
121dSEC
SEC Form 424B4 filed by cbdMD Inc.
424B4 - cbdMD, Inc. (0001644903) (Filer)